Biodesix Strengthens Financial Position With Equity Issuance and Amendment To Term Loan
Approximately $16.3 million in Common Shares Sold Under At-the-market Agreement Used to Offset Prepayment of Debt Second Amendment to $30 Million Term Loan Provides Additional Financial Flexibility for Growth Biodesix, Inc., a leading data-driven diagnostic solutions company with a focus in lung disease, announced the sale of 3,756,994 common shares......